menu
Collapse
Hussam Abu-Farsakh

Hussam Abu-Farsakh

Consultant Histopathologist and Cytopathologist at First Medical Lab at First Medical Lab

Joined 07/12/2016

Summary

I have American Boards in Anatomic and Clinical Pathology in 1993
American Board in Cytopathology in 1995
I did two fellowships
The first one in Fine needle aspiration and Cytopathology at M.D.Anderson Cancer Center
The second one in Surgical Tumor pathology at M.D.Anderson Cancer Center
I did my residency in Anatomic and Clinical Pathology at Baylor Collage of Medicine
I have British membership in Internal medicine part1
I have wide experience in Tumor pathology, hematopathology, neuropathology, dermatopathology and GI pathology
I was an assistant professor in Jordan University Medical School, and I have established the lab at King Hussein Cancer Center in 2001 by being one of the two consultants that build the lab and trained the fellows for 8 years.
I am no the lab director of anatomic and clinical pathology of First Medical Lab in Amman Jordan
Rewards expand_more

Rewards

2

1

0

0

Level: LEVEL 01 (12mo pts: 15 pts)

Rating: 4.56/5 stars (89 ratings)

Lifetime points: 1211 pts

Experience expand_more
Experience
Consultant Histopathologist and Cytopathologist at First Medical Lab
Pathologist at First Medical Lab
Follow back expand_more

Followed by 0

No followers yet.

Activities expand_more

Activities


View More
expand_more
expand_less
Hide
group 0Follower(s)
add
Start a Talk
Panel
Health - Sensing Trends and Disruptions Impacting the Health Workforce
We're assembling an online advisory panel to explore the workforce disruptions impacting the healthcare, life sciences, and wellness industries. Specifically, we'll discuss the technological, social, economic, demographic, environmental, and geopolitical shifts that are shaping the landscape of the healthcare and life sciences workforce and envision what the future holds for the industry.

In this exclusive online panel of 15-20 experts, you'll have the opportunity to learn collaboratively and advance innovation in this field. All engagement is online and at your convenience.
+209
Panel
Improving Safety and Fall Prevention in Hospitals
As clinicians have faced higher patient loads over the last few years, we want to better understand the current safety and risk mitigation practices, the challenges, and new technologies/tools in an effort to determine ways to improve patient safety, patient care, and patient experience.
Panel
The Rise of Value Based Payment Models in Dental Care
Because value-based care models prioritize oral health outcomes and identify ways to lower costs to achieve those improvements, we want are bringing together dental practitioners and insurers to envision how the future of dental care. We are looking to determine how we can leverage value-based care models should work and the biggest challenges to help develop ways to provide better care for patients.
Panel
Trends Impacting the Future of Medicaid for Dental Care
We want to explore the trends impacting the future of Medicaid. We'll discuss current and emerging factors, such as social determinants of health, MCO consolidation, changing demographics, disruptive technologies, new entrants, and beyond – with a focus on dental care.
Panel
Improving the Predicative Modeling of COVID-19
Panel
Testing for COVID-19
Panel
The Future of Hospitals: Returning to Normal CAPEX and Budget Planning Operations
Senior Financial Leadership of Hospitals and Radiation Oncology departments' priorities have shifted. We will aim to track the perspectives and best practices for managing budgets in the face of COVID 19, and the impact on the departments requiring CAPEX investment.
Panel
The Future Treatments of Relapsing-Remitting Multiple Sclerosis
Identify the key steps in the journey of an RRMS patient from symptoms, to diagnosis through to ongoing treatment and potentially disease progression to secondary progressive MS
Panel
Next-Generation Oncology Treatments
Understanding of potential for new cancer drug from Oncologists
Panel
The Future of Multiple Myeloma Treatments & Discoveries
the current and future state of multiple myeloma treatment- the impact of generic availability on foundational therapies and new discoveries. impact on patient management and treatment decisions
Panel
Exploring the Applications of Blockchain for Patients
Applications of blockchain for patients, e.g., control of patient data, monetization of patient data, sharing personal health records for research, etc.
Panel
Exploring Solutions to Obesity Prevention
Obesity Prevention
Solving the Worldwide Obesity Epidemic
Obseity is global epidemic that is not showing signs of slowing down. How do we solve this issue? Does it come down to educating the mothers or the children? Is the solution a change of culture or changing the habits of individuals? What role do food companies play? Do they share the blame with their use of antibiotics and offering of processed foods?
Panel
Exploring the Need for Sensory Cues to Enhance Product Experiences
Do consumers desire sensorial cues in their products?
What advantages do sensory cues, associated with a product, provide to consumers?
How can sensorial cues be leveraged to transform product experiences?
Are there higher order benefits (e.g., anxiety) that could be delivered by manipulating sensorial cues?
Which sensorial cues most drive the perception of efficacy?
What sensorial cues (touch, temperature, etc) are most important to consumers?
Do consumers prefer warm or cool as a sensorial cue?
How concerned are consumers with managing malodors?
How satisfied are consumers with applying fragrances to mask malodors?
If provided with other avenues to counter malodors, such as specific blockers, would consumers be willing to purchase products containing these blockers?
What attributes of current product usage (shampoos, diaper top sheets, clothing, etc) could be improved by altering tactile sensations?


Appealing to consumers' senses (e.g., touch, taste, smell, etc) plays a key role in providing delightful product experiences in the consumer goods market. The specific need is to understand in more depth the key sensory attributes/drivers that are currently targeted within specific business categories (e.g., health care, home care, body and hair care, baby care, feminine products, paper products, etc) across North America, South America and/or Asia, and identifying key GAPs in sensory needs that are not currently being targeted in these regions.

After identifying these GAPS, are there technical approaches that could be pursued to close those gaps (ideally enabled by a Life Sciences approach but all approaches accepted)?

In addition, the need is also to assess across these same businesses and geographies which categories deal with odor as a core consumer benefit (specifically the removal, elimination of malodor or the blocking of its detection or perception). What types of malodors are involved (chemical classes) and what are current technical approaches to eliminate these odors. ID gaps where malodors exist today and where there is not technology. When ID-ing gaps, expand outside FMCGs for inspiration.
Panel
Exploring Transepidermal Neuro-stimulation for the Elderly
Suitability of trans epidermal neuro-stimulation for the elderly

Add at least 3 tags
Your tags